189 related articles for article (PubMed ID: 12946992)
1. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies.
Poppe B; Vandesompele J; Schoch C; Lindvall C; Mrozek K; Bloomfield CD; Beverloo HB; Michaux L; Dastugue N; Herens C; Yigit N; De Paepe A; Hagemeijer A; Speleman F
Blood; 2004 Jan; 103(1):229-35. PubMed ID: 12946992
[TBL] [Abstract][Full Text] [Related]
2. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients.
Zatkova A; Ullmann R; Rouillard JM; Lamb BJ; Kuick R; Hanash SM; Schnittger S; Schoch C; Fonatsch C; Wimmer K
Genes Chromosomes Cancer; 2004 Apr; 39(4):263-76. PubMed ID: 14978788
[TBL] [Abstract][Full Text] [Related]
3. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.
Andersen MK; Christiansen DH; Kirchhoff M; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2001 May; 31(1):33-41. PubMed ID: 11284033
[TBL] [Abstract][Full Text] [Related]
4. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.
Fu JF; Hsu JJ; Tang TC; Shih LY
Genes Chromosomes Cancer; 2003 Jun; 37(2):214-9. PubMed ID: 12696071
[TBL] [Abstract][Full Text] [Related]
5. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.
Poirel H; Rack K; Delabesse E; Radford-Weiss I; Troussard X; Debert C; Leboeuf D; Bastard C; Picard F; Veil-Buzyn A; Flandrin G; Bernard O; Macintyre E
Blood; 1996 Mar; 87(6):2496-505. PubMed ID: 8630416
[TBL] [Abstract][Full Text] [Related]
6. Oncogene amplification in transforming myelodysplasia.
Papenhausen PR; Griffin S; Tepperberg J
Exp Mol Pathol; 2005 Oct; 79(2):168-75. PubMed ID: 16026782
[TBL] [Abstract][Full Text] [Related]
7. Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study.
Tyybäkinoja A; Saarinen-Pihkala U; Elonen E; Knuutila S
Genes Chromosomes Cancer; 2006 Mar; 45(3):257-64. PubMed ID: 16283618
[TBL] [Abstract][Full Text] [Related]
8. Amplification of the 11q23 region in acute myeloid leukemia.
Avet-Loiseau H; Godon C; Li JY; Daviet A; Mellerin MP; Talmant P; Harousseau JL; Bataille R
Genes Chromosomes Cancer; 1999 Oct; 26(2):166-70. PubMed ID: 10469455
[TBL] [Abstract][Full Text] [Related]
9. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
[TBL] [Abstract][Full Text] [Related]
10. Routine fluorescence in situ hybridization with the MLL probe does not reliably detect two separate signals on one chromosome 11 in patients with trisomy 11.
Smith A; Robson L; Heaps LS; Sharma P; Dunlop L; Bhave A; Bradstock K
Cancer Genet Cytogenet; 2001 Sep; 129(2):173-6. PubMed ID: 11566351
[TBL] [Abstract][Full Text] [Related]
11. Variations in MLL amplification in a patient with acute myeloid leukemia.
Brezinová J; Zemanová Z; Cermák J; Kurková S; Sindelárová L; Schwarz J; Michalová K
Leuk Lymphoma; 2002 Oct; 43(10):2031-5. PubMed ID: 12481904
[TBL] [Abstract][Full Text] [Related]
12. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
[TBL] [Abstract][Full Text] [Related]
13. MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23.
Michaux L; Wlodarska I; Stul M; Dierlamm J; Mugneret F; Herens C; Beverloo B; Verhest A; Verellen-Dumoulin C; Verhoef G; Selleslag D; Madoe V; Lecomte M; Deprijck B; Ferrant A; Delannoy A; Marichal S; Duhem C; Dicato M; Hagemeijer A
Genes Chromosomes Cancer; 2000 Sep; 29(1):40-7. PubMed ID: 10918392
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
15. Absence of MLL gene rearrangement in de novo myelodysplastic syndromes (MDS).
Pappa V; Young BD; Economopoulos T; Papageorgiou E; Panani A; Lilington D; Bollas G; Stamouli M; Kontsioti F; Tsiotra P; Vessalas G; Dervenoulas J; Raptis S
Ann Hematol; 2004 Mar; 83(3):170-5. PubMed ID: 15064866
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
17. Jumping translocation at 11q23 with MLL gene rearrangement and interstitial telomeric sequences.
Cuthbert G; McCullough S; Finney R; Breese G; Bown N
Genes Chromosomes Cancer; 1999 Apr; 24(4):295-8. PubMed ID: 10092126
[TBL] [Abstract][Full Text] [Related]
18. Cryptic ins(2;11) with clonal evolution showing amplification of 11q23-q25 either on hsr(11) or on dmin, in a patient with AML-M2.
Vazquez I; Lahortiga I; Agirre X; Larrayoz MJ; Vizmanos JL; Ardanaz MT; Zeleznik-Le NJ; Calasanz MJ; Odero MD
Leukemia; 2004 Dec; 18(12):2041-4. PubMed ID: 15483676
[No Abstract] [Full Text] [Related]
19. Detection of cryptic MLL insertions using a commercial dual-color fluorescence in situ hybridization probe.
Dyson MJ; Talley PJ; Reilly JT; Stevenson D; Parsons E; Tighe J
Cancer Genet Cytogenet; 2003 Nov; 147(1):81-3. PubMed ID: 14580777
[TBL] [Abstract][Full Text] [Related]
20. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
